Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of KBTBD11 mRNA | increases expression | 19933214
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of KBTBD11 mRNA | increases expression | 16788091
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of KBTBD11 mRNA | decreases expression | 20064835
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of KBTBD11 mRNA | decreases expression | 17403535
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of KBTBD11 mRNA | affects cotreatment|increases expression | 17404688
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of KBTBD11 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of KBTBD11 mRNA | increases expression | 18301758
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of KBTBD11 mRNA | affects cotreatment|increases expression | 17404688
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of KBTBD11 mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of KBTBD11 mRNA | increases expression | 19933214
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.13 | 11752688 15322242 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.34 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.43 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.43 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.76 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.87 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.87 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.33 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.86 | 15014928 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.46 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.46 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.66 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.52 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.39 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.39 | 18323546 17388661 12006526 11325840 17020986 15093573 16978400 18234424 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.39 | 16675129 12948864 19861407 17289903 18497071 14630087 17018787 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.39 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.39 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.75 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
3.35 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.35 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.17 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.62 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.10 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.91 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.97 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.01 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.18 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.30 | 17979934 11948286 18710439 15643279 16651033 10498854 10700343 16413132 12161096 16614059 18483878 16989017 18295254 12913760 17010015 18372110 18433785 12388444 18093676 15276878 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.51 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.96 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.24 | 15331540 11751995 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.27 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.59 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.75 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
3.98 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.98 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.23 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.23 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.02 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.11 | 11473722 19148513 18566989 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.58 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.58 | 10568697 9294722 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.47 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.05 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.97 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.21 | 20067830 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.80 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.29 | 16376943 15172196 11014644 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.77 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.77 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.65 | 20558911 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.55 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.85 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.14 | 19772884 16221962 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.14 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.35 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.96 | 16135485 17606976 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.07 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 15340226 18606429 8697196 16354765 16959395 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.38 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18670907 18850075 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.65 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.66 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.75 | 7193160 16517039 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.30 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.30 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
13.07 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
13.07 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
13.07 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.69 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.15 | 15610895 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.58 | 10602166 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.57 | 18587576 17802794 17296974 18172266 17658394 17008537 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.24 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.25 | 10052129 11830472 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.49 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.49 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.49 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.71 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.71 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.71 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.22 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.23 | 18520028 18816296 20064080 18569708 20135361 20464547 20869020 6695378 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.23 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
3.98 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
11.13 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
11.13 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.34 | 11911406 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.48 | 11807958 11408345 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.48 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.80 | 19453300 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
5.06 | 16388313 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.35 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.76 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.21 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.78 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.78 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.83 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
8.83 | 18854779 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.83 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.02 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.27 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.27 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.73 | 8761367 15176712 16115947 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.17 | 12837982 8761367 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.54 | 8291058 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
5.00 | 16517039 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.05 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
5.05 | 16525653 17393432 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.79 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
3.24 | 11332152 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.91 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.48 | 11222880 11399792 11118676 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.09 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.07 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.07 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.07 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.07 | 18760546 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.35 | 16636934 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.47 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.91 | 18045962 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
5.04 | 16636934 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.76 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.76 | 16192470 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.80 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.56 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.34 | 12837982 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.00 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.52 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
5.52 | 14692829 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |